NCT00791817View on ClinicalTrials.gov

Study to Evaluate Potential Food Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Healthy
Interventions
DRUG

PG-760564

200 mg capsule, single dose,fasted when dosed, duration is 4 days

DRUG

PG-760564

200 mg capsule, single dose,high fat diet when dosed, duration is 4 days

Trial Locations (1)

33126

Stuart I Harris, MD, PhD, Miami

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT00791817 - Study to Evaluate Potential Food Effects | Biotech Hunter | Biotech Hunter